12:00 AM
 | 
May 28, 2007
 |  BC Week In Review  |  Company News  |  Deals

Cytyc, Hologic deal

Women's health diagnostic companies HOLX and CYTC will merge. CYTC shareholders will receive $16.50 in cash and 0.52 HOLX shares for each CYTC share owned, which the companies valued at $6.2 billion. CYTC shareholders will own about 55% of the newco, and HOLX shareholders...

Read the full 200 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >